1887

n Cardiovascular Journal of South Africa - Subcutaneous low molecular weight heparins can prevent venous thromboembolisms in pregnancy : drug trends in cardiology

USD

 

Abstract

Extracted from text ... Subcutaneous low molecular weight heparins can prevent venous thromboembolisms in pregnancy Thromboembolism is an infrequent, yet serious cause of both maternal and foetal morbidity and death during pregnancy and the puerperium. Pregnancy itself increases the risk of thromboembolic complications, probably as a result of a combination of hypercoagulability and venous stasis due to venous dilation. Recent studies have indicated that some serious obstetric complications are correlated with inherited or acquired thrombophilia. In retrospective studies the prevalence of venous thromboembolism (VTE) has been estimated to be one per 1 000 to 2 000 pregnancies. Anticoagulant treatment and prophylaxis both before and ..

Loading

Article metrics loading...

/content/cardio/14/1/EJC23801
2003-01-01
2016-12-05
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error